The Impact of Aortic Valvular Calcium on Transcatheter Heart Valve Distortion
Table 1
Patients characteristics.
Overall (n = 118)
Noneccentric calcification group (n = 59)
Eccentric calcification group (n = 59)
value
Age (y)
83.6 ± 5.1
83.0 ± 4.6
84.1 ± 5.5
0.241
Male, n (%)
42 (35.6)
17 (28.8)
25 (42.4)
0.124
Body mass index (kg/m2)
22.7 ± 4.1
23.2 ± 4.6
22.2 ± 3.5
0.201
STS score for mortality
8.2 ± 7.5
7.3 ± 4.0
9.2 ± 9.7
0.177
Logistic euroscore
21.0 ± 12.9
19.2 ± 10.7
22.8 ± 14.7
0.123
Hypertension, n (%)
84 (71.2)
45 (76.3)
39 (66.1)
0.223
Dyslipidemia, n (%)
47 (39.8)
21 (35.6)
26 (44.1)
0.347
Diabetes mellitus, n (%)
29 (24.6)
15 (25.4)
25 (42.4)
0.052
Chronic kidney disease, n (%)
67 (56.8)
30 (50.8)
37 (62.7)
0.193
Cerebral vascular disease, n (%)
44 (37.3)
20 (33.9)
24 (40.7)
0.446
Peripheral vascular disease, n (%)
37 (31.4)
16 (27.1)
21 (35.6)
0.427
Chronic obstructive pulmonary disease, n (%)
24 (20.3)
7 (11.9)
17 (28.8)
0.022
Atrial fibrillation, n (%)
41 (34.7)
17 (28.8)
24 (40.7)
0.176
Prior permanent pacemaker, n (%)
4 (3.4)
2 (3.4)
2 (3.4)
1.000
Prior myocardial infarction, n (%)
10 (8.5)
4 (6.8)
6 (10.2)
0.509
Prior PCI, n (%)
24 (20.3)
17 (28.8)
7 (11.9)
0.022
Prior CABG, n (%)
5 (4.2)
1 (1.7)
4 (6.8)
0.364
Prior BAV, n (%)
2 (1.7)
1 (1.7)
1 (1.7)
1.000
Values are expressed as either mean ± SD or absolute frequency (percentage). STS, Society of Thoracic Surgeons. EuroScore, European System for Cardiac Operative Risk Evaluation. PCI, percutaneous coronary intervention. CABG, coronary artery bypass grafting. BAV, balloon aortic valvuloplasty.
